Cargando…

Molecular Landscape of Small Bowel Adenocarcinoma

SIMPLE SUMMARY: Small bowel adenocarcinoma (SBA) is a rare malignancy with worse prognosis compared to other cancers of the gastrointestinal tract. Over 90% of SBA tumors harbor targetable genetic alterations. Molecular analysis to identify these alterations, using tissue- or blood-based next genera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pandya, Karan, Overman, Michael J., Gulhati, Pat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909755/ https://www.ncbi.nlm.nih.gov/pubmed/35267592 http://dx.doi.org/10.3390/cancers14051287

Ejemplares similares

Phase II Study of Panitumumab in RAS Wild‐Type Metastatic Adenocarcinoma of Small Bowel or Ampulla of Vater
por: Gulhati, Pat, et al.
Publicado: (2017)

Therapeutic Strategies for Patients with Advanced Small Bowel Adenocarcinoma: Current Knowledge and Perspectives
por: Moati, Emilie, et al.
Publicado: (2022)

Reply: Cetuximab in small bowel adenocarcinoma: a new friend?
por: Overman, M J, et al.
Publicado: (2010)

Small Bowel Adenocarcinoma: From Molecular Insights to Clinical Management
por: Gelsomino, Fabio, et al.
Publicado: (2022)

Natural history and prognostic factors for localised small bowel adenocarcinoma
por: Colina, Andreina, et al.
Publicado: (2020)

Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine
por: Overman, M J, et al.
Publicado: (2010)

Metastatic small bowel adenocarcinoma: role of metastasectomy and systemic chemotherapy
por: Bhamidipati, D., et al.
Publicado: (2021)

Adenocarcinoma of Small Bowel
por: Fadavi, Pedram, et al.
Publicado: (2015)

Epidemiology, Risk Factors and Diagnosis of Small Bowel Adenocarcinoma
por: Aparicio, Thomas, et al.
Publicado: (2022)

Localized Small Bowel Adenocarcinoma Management: Evidence Summary
por: Turpin, Anthony, et al.
Publicado: (2022)

Small bowel adenocarcinoma: An overview
por: Khosla, Divya, et al.
Publicado: (2022)

The Evolving Understanding of the Molecular and Therapeutic Landscape of Pancreatic Ductal Adenocarcinoma
por: Parkin, Ashleigh, et al.
Publicado: (2018)

Prognostic Value of Immune Environment Analysis in Small Bowel Adenocarcinomas with Verified Mutational Landscape and Predisposing Conditions
por: Wirta, Erkki-Ville, et al.
Publicado: (2020)

Case Report: Molecular Features and Treatment Options for Small Bowel Adenocarcinoma
por: Cordova-Delgado, Miguel, et al.
Publicado: (2021)

Molecular Landscape and Association With Crohn Disease of Poorly Cohesive Carcinomas of the Nonampullary Small Bowel
por: Tedaldi, Gianluca, et al.
Publicado: (2023)

Molecular profiling and identification of prognostic factors in Chinese patients with small bowel adenocarcinoma
por: Pan, Hongming, et al.
Publicado: (2021)

Characteristics and outcome of patients with small bowel adenocarcinoma (SBA)
por: Teufel, Andreas, et al.
Publicado: (2022)

Persistent Small Bowel Obstruction due to Small Bowel Adenocarcinoma: A Case Report
por: Fleites, Orlando, et al.
Publicado: (2021)

Systemic Treatments for Advanced Small Bowel Adenocarcinoma: A Systematic Review
por: Di Nardo, Paola, et al.
Publicado: (2022)

Landscape of inflammatory bowel disease in Singapore
por: Low, Daren, et al.
Publicado: (2022)

Bevacizumab in metastatic small-bowel adenocarcinoma: A systematic review and meta-analysis
por: Vergara, John Paulo, et al.
Publicado: (2019)

Genomic landscape of lung adenocarcinomas in different races
por: Shi, Huashan, et al.
Publicado: (2022)

Adenocarcinoma of the Small Bowel: A Surgical Dilemma
por: Vagholkar, Ketan, et al.
Publicado: (2009)

Anti‐EGFR Therapy in Small Bowel Adenocarcinoma
por: Safyan, Rachael A., et al.
Publicado: (2018)

Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential
por: Alors-Pérez, Emilia, et al.
Publicado: (2023)

Potential biomarkers and immune characteristics of small bowel adenocarcinoma
por: Feng, Jinggao, et al.
Publicado: (2022)

Adenocarcinoma of Mullerian Origin Presenting as Small Bowel Obstruction
por: Alrasheed, Reema, et al.
Publicado: (2022)

Cetuximab in small bowel adenocarcinoma: a new friend?
por: Santini, D, et al.
Publicado: (2010)

Small bowel adenocarcinoma incarcerated within an inguinal hernia
por: Kawai, Hironari, et al.
Publicado: (2019)

The risk of small bowel adenocarcinoma in patients with Crohn’s disease
por: Lech, Gustaw, et al.
Publicado: (2020)

Small Bowel Adenocarcinoma Mimicking a Crohn’s Attack
por: Yavuz, Arda, et al.
Publicado: (2021)

Retrospective analysis of systemic chemotherapy and total parenteral nutrition for the treatment of malignant small bowel obstruction
por: Chouhan, Jay, et al.
Publicado: (2015)

Epidemiology of adenocarcinomas of the small intestine: is bile a small bowel carcinogen?
por: Ross, R. K., et al.
Publicado: (1991)

Metachronous small bowel adenocarcinoma after rectal adenocarcinoma: A case report
por: Zhen, Ya’nan, et al.
Publicado: (2021)

Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study
por: Aparicio, T, et al.
Publicado: (2013)

Single-cell profiling reveals molecular basis of malignant phenotypes and tumor microenvironments in small bowel adenocarcinomas
por: Yang, Jingwei, et al.
Publicado: (2022)

Comprehensive molecular pathology analysis of small bowel adenocarcinoma reveals novel targets with potential for clinical utility
por: Alvi, Muhammad A., et al.
Publicado: (2015)

Jejunal Adenocarcinoma: A Rare Cause of Small Bowel Obstruction
por: Patel, Jay, et al.
Publicado: (2022)

Small Bowel Epithelial Precursor Lesions: A Focus on Molecular Alterations
por: Vanoli, Alessandro, et al.
Publicado: (2021)

Spermatic cord metastasis as early manifestation of small bowel adenocarcinoma
por: Valizadeh, Nasim, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_493a17m19lfqg440jc318v498l